The NCPE are seeking to recruit a Health Technology Assessor (Closing date 12th May 2019) and a Senior Health Technology Assessor. (Closing date 3rd June 2019) These are full-time, permanent positions. Please click here for further details.
The NCPE recommends that stiripentol (Diacomit®) be considered for reimbursement if cost-effectiveness can be improved relative to existing treatments. This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.
Update on Pharmacoeconomics in the Irish Healthcare Setting, 15th & 16th May 2019 in Dublin Castle. Online access to slides please click here.